About Angiopoietin-related protein 4
Angiopoietin-related protein 4 (ANGPTL4) is a protein
from Homo sapiens identified by UniProt accession
Q9BY76, 406 residues long.
MolForge cross-references it against 0 known binders and
469 disease associations.
Target properties
| Protein name | Angiopoietin-related protein 4 |
| UniProt accession | Q9BY76 |
| Gene | ANGPTL4 |
| Organism | Homo sapiens |
| Length | 406 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (469)
Diseases linked to this target (Open Targets).
- triglyceride measurement · score 0.70
- high density lipoprotein cholesterol measurement · score 0.62
- triglycerides:total lipids ratio · score 0.54
- sphingomyelin measurement · score 0.38
- reticulocyte count · score 0.37
- Red cell distribution width · score 0.37
- phosphatidylcholine measurement · score 0.35
- mean corpuscular volume · score 0.35
- apolipoprotein A 1 measurement · score 0.34
- coronary artery disease · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BY76-F1 | alphafold | PREDICTED | 78.00 | — |
Amino-acid sequence (406 residues)
MSGAPTAGAA LMLCAATAVL LSAQGGPVQS KSPRFASWDE MNVLAHGLLQ LGQGLREHAE RTRSQLSALE RRLSACGSAC QGTEGSTDLP LAPESRVDPE VLHSLQTQLK AQNSRIQQLF HKVAQQQRHL EKQHLRIQHL QSQFGLLDHK HLDHEVAKPA RRKRLPEMAQ PVDPAHNVSR LHRLPRDCQE LFQVGERQSG LFEIQPQGSP PFLVNCKMTS DGGWTVIQRR HDGSVDFNRP WEAYKAGFGD PHGEFWLGLE KVHSITGDRN SRLAVQLRDW DGNAELLQFS VHLGGEDTAY SLQLTAPVAG QLGATTVPPS GLSVPFSTWD QDHDLRRDKN CAKSLSGGWW FGTCSHSNLN GQYFRSIPQQ RQKLKKGIFW KTWRGRYYPL QATTMLIQPM AAEAAS
Explore Angiopoietin-related protein 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets